No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 2859373)

Published in BMC Pulm Med on March 30, 2010

Authors

Albertus J Kooter1, Richard G Ijzerman, Otto Kamp, Anco B Boonstra, Yvo M Smulders

Author Affiliations

1: Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands. jkooter@vumc.nl

Associated clinical trials:

Epoprostenol in Pulmonary Embolism | NCT01014156

Articles cited by this

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med (2002) 8.28

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol (1985) 3.66

Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation (1997) 3.58

Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation (2000) 2.41

Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest (2007) 2.34

Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12

Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med (1997) 2.10

Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med (2005) 1.76

Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest (2001) 1.59

Association between right ventricular function and perfusion abnormalities in hemodynamically stable patients with acute pulmonary embolism. Chest (1998) 1.58

Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets. Chest (1996) 1.47

Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Thromb Res (2009) 1.46

Right ventricular systolic function is not the sole determinant of tricuspid annular motion. Am J Cardiol (2006) 1.43

Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30

Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res (2000) 1.28

Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest (2004) 1.26

Treatment of pulmonary embolism with prostacyclin. Surgery (1980) 1.04

Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs. Chest (2000) 0.97

How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med (2007) 0.97

Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol (1998) 0.94

Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest (1982) 0.93

Prostacyclin for pulmonary hypertension in adults. Cochrane Database Syst Rev (2005) 0.91

Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Intensive Care Med (2007) 0.88

Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol (1987) 0.86

Pulmonary hypertension secondary to minor pulmonary embolism. Chest (1978) 0.85

HUMORAL TRANSMISSION OF CARDIORESPIRATORY CHANGES IN EXPERIMENTAL LUNG EMBOLISM. Circ Res (1964) 0.84

The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med (1996) 0.84

Critical appraisal on the utility of echocardiography in the management of acute pulmonary embolism. Cardiol Rev (2009) 0.83

Effect of prostacyclin on pulmonary vascular response to thrombin in awake sheep. J Appl Physiol (1985) (1986) 0.80

Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism. Am Rev Respir Dis (1987) 0.78

Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice. Thromb Res (1995) 0.77

Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulm Pharmacol Ther (2005) 0.77

Ventilation-perfusion relationships in pulmonary arterial hypertension: effect of intravenous and inhaled prostacyclin treatment. Respir Physiol Neurobiol (2007) 0.77

Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group. Thromb Res (2009) 0.77

Regression of right ventricular hypokinesis after thrombolysis in acute pulmonary embolism. Am J Cardiol (1996) 0.77

Articles by these authors

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37

Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med (2010) 8.17

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum (2009) 2.55

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41

Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res (2009) 2.41

Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28

[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]. Ned Tijdschr Geneeskd (2012) 2.23

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol (2004) 2.10

Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism. J Hypertens (2011) 2.04

Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol (2006) 2.01

General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg (2013) 2.01

The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr (2007) 1.95

Automatic segmentation of echocardiographic sequences by active appearance motion models. IEEE Trans Med Imaging (2002) 1.88

Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation (2002) 1.74

Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J (2005) 1.71

The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Semin Arthritis Rheum (2011) 1.63

Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol (2006) 1.63

Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg (2011) 1.61

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation (2009) 1.55

Birth weight relates to salt sensitivity of blood pressure in healthy adults. Hypertension (2008) 1.55

Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J (2004) 1.54

Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm (2005) 1.52

Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens (2013) 1.52

Quantitative evaluation of myocardial perfusion in patients with revascularized myocardial infarction: comparison between intravenous myocardial contrast echocardiography and 99mTc-sestamibi single photon emission computed tomography. Eur J Echocardiogr (2004) 1.47

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study. Int J Cardiol (2012) 1.41

Two cases of antiruthenium antibody interference in Modular free thyroxine assay. Ann Clin Biochem (2009) 1.39

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33

Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes (2004) 1.32

Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum (2011) 1.29

Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol (2006) 1.28

The potential harm of oxygen therapy in medical emergencies. Crit Care (2013) 1.28

Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography. Eur Heart J (2004) 1.22

Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension (2011) 1.19

Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail (2010) 1.19

Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation (2012) 1.19

Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation (2007) 1.18

Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects. Clin Chem Lab Med (2007) 1.16

Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16

Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis (2004) 1.15

Cardiac disease and cognitive impairment: a systematic review. Heart (2012) 1.14

Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension (2013) 1.13

Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes (2012) 1.13

Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr (2009) 1.11

Three-dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain. J Am Soc Echocardiogr (2011) 1.11

Letter by Lensen et al regarding article, "anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis". Circulation (2013) 1.10

Quantification of left ventricular volumes and ejection fraction using freehand transthoracic three-dimensional echocardiography: comparison with magnetic resonance imaging. J Am Soc Echocardiogr (2003) 1.10

Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function. Eur Heart J Cardiovasc Imaging (2012) 1.09

Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ (2012) 1.08

Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord (2013) 1.07

Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol (2009) 1.07

Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol (2009) 1.07

Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med (2006) 1.05

Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol (2005) 1.04

Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail (2011) 1.02

Three-dimensional echocardiography in mitral valve disease. Eur J Echocardiogr (2005) 1.02

Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes (2007) 1.00

Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib. Anticancer Drugs (2010) 1.00

Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. Diabetes Care (2004) 1.00

Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol (2005) 1.00

Analysis of published PKD1 gene sequence variants. Nat Genet (2007) 0.98

Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels. Ultrasound Med Biol (2007) 0.97

Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep (2011) 0.97

Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. EJNMMI Res (2012) 0.97

[The happy scientist]. Ned Tijdschr Geneeskd (2012) 0.97

Reliability of left ventricular volumes and function measurements using three-dimensional speckle tracking echocardiography. Eur Heart J Cardiovasc Imaging (2011) 0.96

Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large dutch multiethnic cohort. Diabetes Care (2002) 0.96

Carotid arterial remodeling: a maladaptive phenomenon in type 2 diabetes but not in impaired glucose metabolism: the Hoorn study. Stroke (2004) 0.95

Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol Dial Transplant (2008) 0.95

Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation (2012) 0.95

Publication pressure and burn out among Dutch medical professors: a nationwide survey. PLoS One (2013) 0.94

Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. Circulation (2011) 0.94

Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction. J Am Coll Cardiol (2002) 0.93

The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis. Curr Pharm Des (2012) 0.91

Supplemental oxygen therapy in medical emergencies: more harm than benefit? Arch Intern Med (2012) 0.90

Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T. J Am Coll Cardiol (2003) 0.89

RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II. Am Heart J (2006) 0.89

Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study. Heart (2014) 0.89

Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet (2011) 0.89

Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. J Clin Endocrinol Metab (2006) 0.88

Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction. J Am Soc Echocardiogr (2011) 0.88

Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology (2013) 0.88

Emotional exhaustion and burnout among medical professors; a nationwide survey. BMC Med Educ (2014) 0.88

The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus. Clin Chem Lab Med (2006) 0.88

Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia. Biochim Biophys Acta (2013) 0.87

A randomized trial of hemodiafiltration and change in cardiovascular parameters. Clin J Am Soc Nephrol (2014) 0.87

Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease. World J Gastroenterol (2009) 0.87

Microvascular function has no menstrual-cycle-dependent variation in healthy ovulatory women. Microcirculation (2009) 0.87

Fish consumption in healthy adults is associated with decreased circulating biomarkers of endothelial dysfunction and inflammation during a 6-year follow-up. J Nutr (2011) 0.87

ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest (2008) 0.86

Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol (2009) 0.86

Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no Pseudoxanthoma Elasticum phenotype. Int J Cardiol (2005) 0.86

Effects of breath-holding position on the QRS amplitudes in the routine electrocardiogram. J Electrocardiol (2009) 0.86

Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab (2008) 0.86

Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diabetes Care (2003) 0.86

Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels. Nephrol Dial Transplant (2011) 0.86

Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome? Essays Biochem (2006) 0.86

Giant cell arteritis: heterogeneity in clinical presentation and imaging results. J Vasc Surg (2008) 0.85

Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon--the Hoorn Study. Kidney Int (2005) 0.85

Plasma choline and betaine correlate with serum folate, plasma S-adenosyl-methionine and S-adenosyl-homocysteine in healthy volunteers. Clin Chem Lab Med (2013) 0.85